(1.17%) 5 123.54 points
(1.15%) 38 667 points
(1.91%) 16 143 points
(-0.62%) $78.46
(5.45%) $2.15
(-0.22%) $2 304.50
(-0.47%) $26.70
(0.20%) $964.55
(-0.37%) $0.929
(-1.24%) $10.86
(-0.10%) $0.797
(0.35%) $91.44
Live Chart Being Loaded With Signals
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally...
Stats | |
---|---|
Dagens volum | 3 162.00 |
Gjennomsnittsvolum | 200 148 |
Markedsverdi | 36.18M |
EPS | $0 ( 2024-04-01 ) |
Neste inntjeningsdato | ( $-0.0500 ) 2024-05-15 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.340 |
ATR14 | $0.0410 (1.52%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-09-07 | Zukiwski Alexander A | Buy | 3 000 | Employee Stock Option (Right to Buy) |
2022-09-06 | Huang James | Buy | 33 300 | Common Stock |
2022-08-31 | Huang James | Buy | 400 | Common Stock |
2022-08-24 | Huang James | Buy | 39 527 | Common Stock |
2022-08-19 | Huang James | Buy | 40 000 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 95 transactions |
Buy: 27 815 562 | Sell: 9 916 643 |
CASI Pharmaceuticals Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
TTEC | 0.951 |
UONEK | 0.948 |
UONE | 0.942 |
CNXC | 0.939 |
PRTS | 0.936 |
JRJC | 0.934 |
HCDIP | 0.933 |
AMPH | 0.929 |
PHCF | 0.929 |
VORB | 0.927 |
10 Mest negative korrelasjoner | |
---|---|
RNA | -0.953 |
PPC | -0.95 |
VITL | -0.947 |
GRCL | -0.942 |
MLAI | -0.941 |
CRAI | -0.94 |
MNMD | -0.94 |
RETA | -0.937 |
THRN | -0.936 |
IMPPP | -0.936 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
CASI Pharmaceuticals Inc Økonomi
Annual | 2023 |
Omsetning: | $33.88M |
Bruttogevinst: | $18.98M (56.03 %) |
EPS: | $-2.02 |
FY | 2023 |
Omsetning: | $33.88M |
Bruttogevinst: | $18.98M (56.03 %) |
EPS: | $-2.02 |
FY | 2022 |
Omsetning: | $43.11M |
Bruttogevinst: | $27.28M (63.28 %) |
EPS: | $-2.89 |
FY | 2021 |
Omsetning: | $30.17M |
Bruttogevinst: | $17.61M (58.38 %) |
EPS: | $-0.332 |
Financial Reports:
No articles found.
CASI Pharmaceuticals Inc
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma (B-NHL); BI-1206 that is in Phase I/II trial in combination with anti-PD1 therapy Keytruda for solid tumors, and in a Phase I/IIa trial in combination with MabThera (rituximab) in patients with relapsed/refractory NHL; and CB-5339, which is in Phase I clinical trial for acute myeloid leukemia and myelodysplastic syndrome. Its product pipeline also comprises CID-103 for the treatment of patients with multiple myeloma; Thiotepa, which has multiple indications including use as a conditioning treatment for various allogeneic haemopoietic stem cell transplants; and Octreotide long acting injectable formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumors. The company has licensing agreements with Juventas Cell Therapy Ltd; BioInvent International AB; Black Belt Therapeutics Limited; and Cleave Therapeutics, Inc. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co., Ltd; Pharmathen Global BV; and Riemser Pharma GmbH. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Rockville, Maryland.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.